Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Replimune Group, Inc. publishes a filing, an earnings call transcript or a press release.

Get REPL alerts

About Christy Oliger

Christy Oliger is recorded as Board Member at Replimune Group, Inc. (REPL) and Board Member at Vera Therapeutics, Inc. (VERA) since January 1, 2024. The newest filing on record that lists Christy Oliger as Board Member at Replimune Group, Inc. (REPL) is dated July 29, 2026. The newest filing on record that lists Christy Oliger as Board Member at Vera Therapeutics, Inc. (VERA) is dated April 9, 2026. Vera Therapeutics, Inc. reported in an 8-K filed June 12, 2024 that Christy Oliger was appointed Class III Director, effective June 7, 2024. Replimune Group, Inc. is classified in the Biotechnology industry within the Healthcare sector. Vera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Replimune Group, Inc. includes Dr. Sushil Patel (CEO and Board Member), Sushil Patel (CEO and Board Member), Dieter Weinand (Chairman and Board Member) and 7 others.

“On June 7, 2024, the board of directors (the "Board") of Vera Therapeutics, Inc. (the "Company") appointed Christy Oliger to the Board, effective immediately.”
Vera Therapeutics, Inc. Form 8-K, filed June 12, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Replimune Group, Inc.

Leadership on record at Vera Therapeutics, Inc.

Recent activity